Nevro Corp. Announces Publication Of Positive Six-Month Clinical Data For Senza® HF10™ High-Frequency Spinal Cord Stimulation Therapy In Europe
Caution – Investigational device, limited by United States law to investigational use.
Media Contact: Nicole Osmer (U.S.)Tel: 650-454-0504Email: email@example.com
Mike Sinclair (UK)Tel: 020 7318 2955Email: firstname.lastname@example.org
SOURCE Nevro Corp.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts